Fosun Pharmaceutical: the new tablet production line of the holding subsidiary passed the GMP compliance inspection
Fosun Pharmaceutical announced that, according to the recent public information on the website of Jiangsu Provincial Drug Administration, the newly added tablet production line of Suzhou Erye, the holding subsidiary of the company, located in Xiangcheng District, Suzhou City, has passed the GMP compliance inspection.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Nov 08, 2022 08:32 AM
Briefing Jun 27, 2022 07:49 AM
· Technology
New energy players flocking to carbon nanotube materials to grab high growth single products
Automotive
BYD Is Planning EV Production in Thailand by 2024
Thailand’s Ministry of Finance has now approved 26 electric car projects from 17 companies, which are expected to add up to a total production capacity of 830,000 electric vehicles. This is expected to increase to one million electric vehicles by early 2023.
Sep 08, 2022 04:58 PM
Briefing Jun 20, 2022 12:24 PM
· Automotive
Analysis of midday limit on June 20
Briefing Jun 17, 2022 07:14 AM
· Automotive
Transformation and acceleration several auto companies stated that they would stop producing fuel vehicles
Briefing Jun 12, 2022 07:03 PM
· Automotive
Longji machinery: BYD's new energy vehicles and other models are supported by the company, accounting for more than 85%
See more
Read next
Insight
In-depth
Technology · Analysis
CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future
Yesterday 12:26 PM
Insight
In-depth
Insight
In-depth
Insight
In-depth